Rhenman & Partners Asset Management AB Buys 39,000 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […]

Related Keywords

United States ,Canada ,Washington ,Roger Jeffs ,Markl Jacobson ,Axsome Therapeutics Inc ,Citigroup ,Nasdaq ,Washington Trust Advisors Inc ,Sg Americas Securities ,Cantor Fitzgerald ,Royal Bank ,Securities Exchange Commission ,Morgan Stanley ,Partners Asset Management ,Axsome Therapeutics ,Free Report ,Trust Advisors ,Ivy Capital Management ,Aigen Investment Management ,Director Roger Jeffs ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Axsome Therapeutics Daily ,